Editas Medicine
EDITEditas Medicine is a clinical-stage biotechnology company which is developing therapies based on CRISPR–Cas9 gene editing technology. Editas is based in Cambridge, Massachusetts and has facilities in Boulder, Colorado. It was founded in 2013 with funding from Third Rock Ventures, Polaris Partners an …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Editas Medicine
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/5/2024 | Sell | O'neill, Gilmore Neil | CEO | $9.4 | $732,884 |
| 3/4/2024 | Sell | Mei, Baisong | SVP, CHIEF MEDICAL OFFICER | $9.4 | $191,425 |
| 12/5/2023 | Sell | Eaton, Bruce | EVP, CBO AND CTO | $10.9 | $1,122 |
| 11/14/2023 | Sell | Eaton, Bruce | EVP, CBO AND CTO | $8.2 | $5,706 |
| 11/7/2023 | Sell | Eaton, Bruce | EVP, CBO AND CTO | $8.4 | $1,168 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)